Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes |
| |
Authors: | Rodella Luigi Lamon Brian D Rezzani Rita Sangras Bhavani Goodman Alvin I Falck John R Abraham Nader G |
| |
Institution: | aUniversity of Texas Southwestern Medical Center, Dallas, TX, USA bDepartment of Pharmacology, New York Medical College, Valhalla, NY 10595, USA cDivision of Human Anatomy, Department of Biomedical Sciences and Biotechnology, University of Brescia, Italy dDepartment of Medicine, New York Medical College, Valhalla, NY 10595, USA |
| |
Abstract: | Hyperglycemia has been linked to increased oxidative stress, a resultant endothelial cell dysfunction, and, ultimately, apoptosis. Heme oxygenases (HO-1/HO-2) and the products of their activity, biliverdin/bilirubin and carbon monoxide (CO), play a physiological role in the vascular system. The effects of heme-mediated HO-1 induction, CO, and biliverdin on urinary 8-epi-isoprostane PGF2 and endothelial cell sloughing were examined in an animal model of streptozotocin (STZ)-induced diabetes. Hyperglycemia itself did not affect HO-1 and HO-2 protein levels, but caused a net decrease in HO activity. Weekly heme administration induced HO-1 protein, as demonstrated by immunohistochemistry and Western blot analyses. Administration of biliverdin or the CO donor, CORM-3, decreased urinary 8-epi-isoprostane PGF2 , P < 0.5 compared to diabetes. Hyperglycemia increased endothelial cell sloughing; 8.2 ± 0.8 cells/ml blood in control rats vs. 48 ± 4.8 cells/ml blood in diabetic rats (P < 0.05). Heme administration significantly increased endothelial cell sloughing in diabetic rats (98 ± 8.1 cells/ml blood, P < 0.0007) whereas biliverdin modestly decreased endothelial cell sloughing (26 ± 3.5 cells/ml blood, P < 0.003). Administration of CORM-3 to diabetic rats resulted in a significant decrease in endothelial cell sloughing to 21.3 ± 2.3 (P < 0.001). Administration of SnMP to CORM-3 diabetic rats only partially reversed the protective effects of CORM-3 on endothelial cell sloughing from 21.3 ± 2.3 to 29 ± 2.1 cells/ml, thus confirming a direct protective of CO, in addition to the ability of CORM-3 to induce HO-1 protein. These results demonstrate that exogenously administered CO or bilirubin can prevent endothelial cell sloughing in diabetic rats, likely via a decrease in oxidative stress, and thus represents a novel approach to prophylactic vascular protection in diabetes. |
| |
Keywords: | Heme oxygenase Carbon monoxide Biliverdin/bilirubin Diabetes Oxidants Circulating endothelial cells Free radicals |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|